July is Fragile X Awareness Month: We’re sharing stories from families affected by Fragile X and the pediatric specialists who work with them.
Signatera is a bespoke mPCR-NGS assay for detection and quantification of circulating tumor DNA (ctDNA) in the plasma of patients previously diagnosed with cancer.
Tarazona N, Henriksen TV, Carbonell-Asins JA, et al. Oral presentation at: American Society of Clinical Oncologist; May 29-31, 2020; Virtual Meeting. Abstract 4009